Table 4.
Normal TG | Differential TG | Biological Pathway1 |
---|---|---|
CCT5, MCFD2, PDIA6 | cellular protein metabolic process | |
RAD51 | MYC | cellular response to DNA damage stimulus |
RAD51 | SSRP1 | DNA repair |
RRM2 | SSRP1 | DNA replication |
GNB2, MYC | energy reserve metabolic process | |
RCC1, RRM2 | G1/S transition of mitotic cell cycle | |
CNOT6, MYC, SSRP1 | gene expression | |
GMPS, IMPDH2 | GMP biosynthetic process | |
HELLS | IMPDH2 | lymphocyte proliferation |
HELLS, RCC1 | mitosis | |
HELLS, IGF1R, VEGFA | MYC | negative regulation of apoptotic process |
VEGFA | MYC | negative regulation of transcription from RNA polymerase II promoter |
RRM2 | GMPS, IMPDH2 | nucleobase-containing small molecule metabolic process |
RRM2 | IMPDH2, LDHA | oxidation-reduction process |
IGF1R, VEGFA | positive regulation of cell migration | |
IGF1R, VEGFA | CNOT6, MYC, NACC1 | positive regulation of cell proliferation |
VEGFA | MYC | positive regulation of epithelial cell proliferation |
VEGFA | MYC | positive regulation of mesenchymal cell proliferation |
IGF1R, VEGFA | positive regulation of protein kinase B signaling | |
VEGFA | MYC | positive regulation of transcription from RNA polymerase II promoter |
CCT5, PDIA6 | protein folding | |
RAD51 | NACC1 | protein homooligomerization |
CPM | ADAM28 | proteolysis |
GMPS, IMPDH2 | purine nucleobase metabolic process | |
GMPS, IMPDH2 | purine nucleotide biosynthetic process | |
GMPS, IMPDH2 | purine ribonucleoside monophosphate biosynthetic process | |
CNOT6, MYC, SSRP1 | regulation of transcription, DNA-dependent | |
RRM2 | GMPS, GNB2, IMPDH2, LDHA | small molecule metabolic process |
HELLS | CNOT6, MYC, NACC1 | transcription, DNA-templated |
RCC1 | SSRP1 | viral process |
Pathways that were regulated by more than one TG were included in the table. Lines shaded in gray contain pathways that were identified for more than one TG in both normal and differential colonic mucosa.